Journal ID (nlm-ta): PLoS Med
Journal ID (iso-abbrev): PLoS Med
Journal ID (publisher-id): plos
Journal ID (pmc): plosmed
Title:
PLoS Medicine
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Print):
1549-1277
ISSN
(Electronic):
1549-1676
Publication date
(Electronic):
6
September
2019
Publication date Collection:
September
2019
Volume: 16
Issue: 9
Electronic Location Identifier: e1002915
Affiliations
[1
]
Unité Mixte Internationale TransVIHMI, UMI 233 IRD–U1175 INSERM—Université de Montpellier,
Institut de Recherche pour le Développement (IRD), Montpellier, France
[2
]
Division of TB Elimination, National Center for HIV, Viral Hepatitis, STD and TB Prevention,
Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
[3
]
Office of Anti-infective and Vaccines, Human Medicines Evaluation, European Medicines
Agency, Amsterdam, the Netherlands
[4
]
Division of Anti-Infective Products, Center for Drug Evaluation and Research, US Food
and Drug Administration, Silver Spring, Maryland, United States of America
[5
]
Division of Pulmonary and Critical Care Medicine, Center for Tuberculosis, University
of California, San Francisco, San Francisco, California, United States of America
Author notes
I have read the journal's policy and the authors of this manuscript have the following
competing interests: At the CDC, AAV serves as part of a research group doing clinical
trials in tuberculosis. His group (TBTC) works often in collaboration with pharmaceutical
companies, who may provide modest support, such as drug supplies or funding for PK
sub-studies. One company, Sanofi, has provided 6 unrestricted grants to the CDC Foundation
over the years 2007–2015 totaling ~$2.8 million to facilitate or support TBTC work
related to rifapentine. These funds have supported several PK sub-studies, supported
3 contract research staff, have funded travel to TBTC scientific meetings for invited
speakers (all in coach class), and have supported expenses related to fulfillment
of company requests for data and data formats as part of their efforts to use TBTC
data to support regulatory filings. None of these funds have otherwise benefited members
of his research group.
Author information
Article
Publisher ID:
PMEDICINE-D-18-04373
DOI: 10.1371/journal.pmed.1002915
PMC ID: 6730844
PubMed ID: 31490921
SO-VID: a947e706-9224-4766-af3c-53f391bace9b
Copyright © © 2019 World Health Organization
License:
Licensee Public Library of Science. This is an open access article distributed under
the Creative Commons Attribution IGO License, which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
http://creativecommons.org/licenses/by/3.0/igo/. In any use of this article, there should be no suggestion that WHO endorses any
specific organization, products or services. The use of the WHO logo is not permitted.
This notice should be preserved along with the article's original URL.
No specific funding was received for this study. No funding bodies had any role in
study design, data collection and analysis, decision to publish, or preparation of
the manuscript.
Subject:
Collection Review
Subject:
Medicine and Health Sciences
Subject:
Infectious Diseases
Subject:
Bacterial Diseases
Subject:
Tuberculosis
Subject:
Medicine and Health Sciences
Subject:
Tropical Diseases
Subject:
Tuberculosis
Subject:
Medicine and Health Sciences
Subject:
Health Care
Subject:
Health Care Policy
Subject:
Medicine and Health Sciences
Subject:
Clinical Medicine
Subject:
Clinical Trials
Subject:
Medicine and Health Sciences
Subject:
Pharmacology
Subject:
Drug Research and Development
Subject:
Clinical Trials
Subject:
Research and Analysis Methods
Subject:
Clinical Trials
Subject:
Medicine and Health Sciences
Subject:
Pharmacology
Subject:
Drug Research and Development
Subject:
Medicine and Health Sciences
Subject:
Health Care
Subject:
Health Care Policy
Subject:
Drug Policy
Subject:
Medicine and Health Sciences
Subject:
Public and Occupational Health
Subject:
Drug Policy
Subject:
Medicine and Health Sciences
Subject:
Pharmaceutics
Subject:
Drug Therapy
Subject:
Medicine and Health Sciences
Subject:
Public and Occupational Health
Subject:
Science Policy